SOPHARMA AD - Sales revenues for March 2022

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 14 / 2022

Date of issue: 2022-04-05

Short name of the issuer

SOPHARMA AD

Subject

Sales revenues for March 2022

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

“Sopharma” AD (the Company) notifies that for March 2022 the Company recorded a decrease in sales of 23% compared to the same month of the previous year, incl. 10% increase in domestic sales and 55% decrease in export sales. The reduced activity on the main foreign markets is a result of Russia's hostile invasion of Ukraine and consequently the Company's inability to maintain a normal supply of pharmaceutical, OTC and other health-related products to the countries participating in the war. For the first quarter the revenues from sales of products increase by 29%, incl. 80% increase of sales for the domestic market and 3% decrease in export sales.

Annexes

File Description

Sales_Revenues_for_March_2021_espi.pdf Sales revenues for March 2022

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2022-04-05 Ognian Donev Executive Director